FTO and hepatocellular carcinoma: Our results revealed a notable reduction in FTO expression within highly metastatic cell lines (MHCC97H and HCCLM3) compared to less metastatic HCC cell lines (HepG2 and MHCC97L) at both the mRNA (P < 0.01, Fig. 2c) and protein levels (Fig. 2d).